We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Cholangiolitic Hepatitis Clinical-Pathologic Studies and Response to Steroid Therapy in Four Cases

AMA Arch Intern Med. 1959;103(6):859-870. doi:10.1001/archinte.1959.00270060011003.
Text Size: A A A
Published online


Introduction  A chronic form of hepatitis, which was predominantly obstructive, was originally recognized by Eppinger.1 Watson and Hoffbauer2 later used the term "cholangiolitic hepatitis" in referring to patients with a similar clinical picture. In addition, other reports,3-6 substantiated by epidemiological data, have indicated that acute viral hepatitis is capable of inducing an illness with clinical and laboratory features typical of regurgitation jaundice. In cholangiolitic hepatitis the clinical manifestation of a relative sense of well-being is in marked contrast to the biochemical abnormalities. There are usually an appreciable degree of pruritus (associated with acholic stools), low urinary urobilinogen, hyperbilirubinemia (high direct fraction), bilirubinuria, high alkaline phosphatase, and hypercholesteremia. This is in marked contrast to the relatively normal "flocculation" tests. A review of the previously described cases disclosed many with mildly abnormal hepatocellular tests, and the diagnosis of cholangiolitic hepatitis was used to indicate these predominant clinical and biochemical


Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

7 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.